{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:30:39Z","timestamp":1764916239956,"version":"3.46.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Numerous systematic reviews (SRs) and meta-analyses (MAs) have investigated the clinical effectiveness of acupuncture therapy (AT) for fibromyalgia syndrome (FMS); however, the quality and consistency of the evidence remain unclear. This study aimed to evaluate the methodological quality and strength of evidence in published SRs and MAs on the efficacy and safety of AT for FMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted in 11 databases up to May 2025. Two reviewers independently selected studies, extracted data, and assessed methodological quality using A MeaSurement Tool to Assess systematic Reviews-2 (AMSTAR-2), reporting quality via Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 and certainty of evidence with Grading of Recommendations Assessment, Development, and Evaluation (GRADE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen SRs and MAs were included. According to AMSTAR-2, only one SR and MA was rated high quality, three were moderate, and eight were low or critically low, respectively. Following the PRISMA guidelines, five SRs demonstrated compliance &amp;gt;85%. No high-quality evidence with GRADE assessment was found. The overall quality of evidence in the included SRs ranged from \u201cvery low\u201d to \u201cmoderate.\u201d AT was found to be superior to sham AT or standard pharmacological therapies (SPT) in treating FMS and pain. Evidence from 10 SRs (collectively reporting on 63 outcomes) indicated that AT provided superior pain relief than sham AT or SPT. AT was more effective than sham AT (Visual Analog Scale; mean difference [MD] \u22121.04 [\u22121.70, \u22120.38],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002) and SPT (MD \u22121.77 [\u22122.10, \u22121.44],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.00001) in reducing pain. It also showed significantly better long-term pain relief (standard mean difference [SMD] 0.40 [\u22120.77, \u22120.03],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.03), lower Fibromyalgia Impact Questionnaire scores (SMD \u22120.69 [\u22120.91, \u22120.47],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.00001), reduced fatigue (SMD \u22120.03 [\u22120.42, 0.35],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.87), reduced number of tender points (SMD \u22122.38 [\u22123.40, \u22121.37],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.00001), and increased pain pressure threshold (SMD 0.31 [0.02, 0.61],\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.04). No adverse effects attributed to AT were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current SRs and MAs provide low-quality evidence for the effectiveness of AT in treating FMS. Robust and well-designed studies using standardized methods are needed to provide more reliable and convincing evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024536968<\/jats:uri>\n                      , Identifier CRD42024536968.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1712065","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:25:14Z","timestamp":1764915914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acupuncture for fibromyalgia syndrome: an overview of systematic reviews and meta-analyses"],"prefix":"10.3389","volume":"12","author":[{"given":"Tae-Young","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hee","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myeong Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fpsyg.2018.00377","article-title":"Cognitive impairments in fibromyalgia syndrome: associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem","volume":"9","author":"Galvez-S\u00e1nchez","year":"2018","journal-title":"Front Psychol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","article-title":"Prevalence of fibromyalgia: literature review update","volume":"57","author":"Marques","year":"2017","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5114\/reum\/163094","article-title":"Fibromyalgia - etiology, diagnosis and treatment including perioperative management in patients with fibromyalgia","volume":"61","author":"Dizner-Golab","year":"2023","journal-title":"Reumatologia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","article-title":"Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update","volume":"22","author":"Siracusa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1046\/j.1525-1497.2000.06279.x","article-title":"Treatment of fibromyalgia with antidepressants: a meta-analysis","volume":"15","author":"O'Malley","year":"2000","journal-title":"J Gen Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00484-024-02732-3","article-title":"Effectiveness of balneotherapy in reducing pain, disability, and depression in patients with fibromyalgia syndrome: a systematic review with meta-analysis","volume":"68","author":"Garc\u00eda-L\u00f3pez","year":"2024","journal-title":"Int J Biometeorol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/jcm10071493","article-title":"Balneotherapy for fibromyalgia syndrome: a systematic review and meta-analysis","volume":"10","author":"Cao","year":"2021","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"25085","DOI":"10.52965\/001c.25085","article-title":"Efficacy of acupuncture in the treatment of fibromyalgia","volume":"13","author":"Berger","year":"2021","journal-title":"Orthop Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jpain.2017.11.005","article-title":"Acupuncture for chronic pain: update of an individual patient data meta-analysis","volume":"19","author":"Vickers","year":"2018","journal-title":"J Pain"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1142\/S0192415X21500543","article-title":"Efficacy of acupuncture for insomnia: a systematic review and meta-analysis","volume":"49","author":"Kim","year":"2021","journal-title":"Am J Chin Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"CD004046","DOI":"10.1002\/14651858.CD004046.pub4","article-title":"Acupuncture for depression","volume":"2018","author":"Smith","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ALN.0000000000000101","article-title":"Mechanisms of acupuncture-electroacupuncture on persistent pain","volume":"120","author":"Zhang","year":"2014","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13643-017-0487-6","article-title":"An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools","volume":"6","author":"Perry","year":"2017","journal-title":"Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s13643-019-1252-9","article-title":"Preferred reporting items for overviews of reviews (PRIOR): a protocol for development of a reporting guideline for overviews of reviews of healthcare interventions","volume":"8","author":"Pollock","year":"2019","journal-title":"Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/jrsm.1658","article-title":"Estimating pairwise overlap in umbrella reviews: considerations for using the corrected covered area (CCA) index methodology","volume":"14","author":"Kirvalidze","year":"2023","journal-title":"Res Synth Methods"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jrsm.1390","article-title":"Examining overlap of included studies in meta-reviews: guidance for using the corrected covered area index","volume":"11","author":"Hennessy","year":"2020","journal-title":"Res Synth Methods"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/rheumatology\/kel406","article-title":"Acupuncture for fibromyalgia-a systematic review of randomized clinical trials","volume":"46","author":"Mayhew","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"ref22","first-page":"35","article-title":"The efficacy of acupuncture in the treatment of fibromyalgia syndrome","author":"Daya","year":"2007","journal-title":"J Acupuncture Assoc Chartered Physiotherapists"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1874312900903010025","article-title":"Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials","volume":"3","author":"Martin-Sanchez","year":"2009","journal-title":"Open Rheumatol J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/rheumatology\/kep439","article-title":"Efficacy of acupuncture in fibromyalgia syndrome\u2014a systematic review with a meta-analysis of controlled clinical trials","volume":"49","author":"Langhorst","year":"2010","journal-title":"Rheumatology"},{"key":"ref25","first-page":"112","article-title":"Comparing the effectiveness of acupuncture and western medicine in the treatment of fibromyalgia syndrome: a systematic review","volume":"16","author":"Gao","year":"2010","journal-title":"Chin J Pain Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"362831","DOI":"10.1155\/2013\/362831","article-title":"Acupoint stimulation for fibromyalgia: a systematic review of randomized controlled trials","volume":"2013","author":"Cao","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"CD007070","DOI":"10.1002\/14651858.CD007070.pub2","article-title":"Acupuncture for treating fibromyalgia","volume":"2013","author":"Deare","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0254-6272(15)30037-6","article-title":"Efficacy of acupuncture on fibromyalgia syndrome: a meta-analysis","volume":"34","author":"Yang","year":"2014","journal-title":"J Tradit Chin Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8757685","article-title":"Comparing verum and sham acupuncture in fibromyalgia syndrome: a systematic review and meta-analysis","volume":"2019","author":"Kim","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/JPR.S186227","article-title":"Acupuncture therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Zhang","year":"2019","journal-title":"J Pain Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1093\/pm\/pnaa321","article-title":"Effectiveness of invasive techniques in patients with fibromyalgia: systematic review and meta-analysis","volume":"21","author":"Sarmiento-Hern\u00e1ndez","year":"2020","journal-title":"Pain Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JPR.S351320","article-title":"Effect of acupuncture on pain, fatigue, sleep, physical function, stiffness, well-being, and safety in fibromyalgia: a systematic review and Meta-analysis","volume":"15","author":"Zheng","year":"2022","journal-title":"J Pain Res"},{"key":"ref33","first-page":"944","article-title":"Meta-analysis of the effectiveness of acupuncture in the treatment of fibromyalgia","volume":"28","author":"Yang","year":"2022","journal-title":"Chin J Pain Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4065\/81.6.749","article-title":"Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial","volume":"81","author":"Martin","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-143-1-200507050-00005","article-title":"A randomized clinical trial of acupuncture compared with sham acupuncture in fibromyalgia","volume":"143","author":"Assefi","year":"2005","journal-title":"Ann Intern Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/bmj.305.6864.1249","article-title":"Electroacupuncture in fibromyalgia: results of a controlled trial","volume":"305","author":"Deluze","year":"1992","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1089\/acm.2005.11.663","article-title":"Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency","volume":"11","author":"Harris","year":"2005","journal-title":"J Altern Complement Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European league against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1712065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:25:15Z","timestamp":1764915915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1712065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":40,"alternative-id":["10.3389\/fmed.2025.1712065"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1712065","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1712065"}}